Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder With Hyperactivity

Explore clinical trials studying Attention Deficit Disorder With Hyperactivity. Study availability and eligibility vary by location and protocol.

163 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder With Hyperactivity trial results

Completed

NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study

NCT00595751

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Dothan, Alabama, United States
  • Indian Crest Pediatrics Westminster, Colorado, United States
  • Medical College of Georgia Augusta, Georgia, United States
  • Mercer University School of Medicine Macon, Georgia, United States
View Trial Details
Completed

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

NCT00174226

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View Trial Details
Completed

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

NCT00386581

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russia
View Trial Details
Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

NCT00190931

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, Missouri, United States
View Trial Details

Related conditions